跳至主要内容
临床试验/NCT02978898
NCT02978898已完成不适用

CD180 Overexpression in Follicular Lymphoma Is Restricted to the Lymph Node Compartment

Hospices Civils de Lyon0 个研究点目标入组 184 人开始时间: 2012年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
184
主要终点
Immunophenotype Analysis by Flow Cytometry of peripheral blood samples at inclusion

研究概览

简要总结

Background:Altered Toll-like receptor (TLR) expression levels and/or mutations in its signaling pathway (such as MyD88 mutation) contribute to the pathogenesis of lymphoproliferative disorders (LPD). CD180 is an orphan member of the TLR family that modulates the signaling of several TLRs, but only limited studies have evaluated its expression by flow cytometry (FCM) in LPD.

Methods: Using a multiparameter FCM approach, biologists have assessed CD180 mean fluorescence intensity (MFI) in lymph nodes (LNs) and peripheral blood (PB) samples obtained from patients with follicular lymphoma (FL; LN/PB, n=44/n=15), chronic lymphocytic leukemia (CLL, n=26/n=21), mantle cell lymphoma (MCL, n=13/n=17), and marginal zone lymphoma (MZL, n=16/n=12). Specimens from non-tumoral PB and LN (n=8/n=12) were used as controls.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Retrospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Samples from patients with:
  • LF: Follicular lymphoma
  • MCL: Mantle cell lymphoma
  • CLL/SLL: chronic lymphocytic leukemia/small lymphocytic leukemia
  • MZL : splenic marginal zone
  • Clt :control B-cells

排除标准

  • Patient <18 years old

结局指标

主要结局

Immunophenotype Analysis by Flow Cytometry of peripheral blood samples at inclusion

时间窗: At inclusion, day 0.

Using a multiparameter FCM approach, biologists assessed the CD180 expression by our routine antigen panel in LN suspensions as well as in PB samples. Samples were analyzed on a BD FACSCanto II cytometer (BD FACS DIVA software; Becton Dickinson, San Jose, CA).

Immunophenotype Analysis by Flow Cytometry of lymph nodes samples at inclusion

时间窗: At inclusion, day 0.

Using a multiparameter FCM approach, biologists assessed the CD180 expression by our routine antigen panel in LN suspensions as well as in PB samples. Samples were analyzed on a BD FACSCanto II cytometer (BD FACS DIVA software; Becton Dickinson, San Jose, CA).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验